Assetmark Inc. boosted its stake in shares of Clorox Co (NYSE:CLX) by 31.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,804 shares of the company’s stock after buying an additional 8,762 shares during the quarter. Assetmark Inc.’s holdings in Clorox were worth $5,635,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of CLX. Zions Bancorporation N.A. acquired a new position in Clorox during the first quarter worth approximately $28,000. Northstar Capital Management LLC acquired a new position in Clorox during the first quarter worth approximately $29,000. Heritage Wealth Advisors acquired a new position in Clorox during the second quarter worth approximately $30,000. Penserra Capital Management LLC acquired a new position in Clorox during the first quarter worth approximately $36,000. Finally, Rational Advisors LLC increased its position in Clorox by 59.5% during the first quarter. Rational Advisors LLC now owns 276 shares of the company’s stock worth $44,000 after purchasing an additional 103 shares during the last quarter. Institutional investors own 78.18% of the company’s stock.
In related news, SVP Michael R. Costello sold 6,997 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the completion of the sale, the senior vice president now directly owns 29,016 shares in the company, valued at $4,716,840.96. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director A D. David Mackay sold 3,400 shares of Clorox stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,609 shares of company stock worth $2,497,443. 1.14% of the stock is owned by corporate insiders.
Several equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. reissued an “underweight” rating and issued a $137.00 price objective (down previously from $143.00) on shares of Clorox in a research report on Thursday, October 3rd. Morgan Stanley reissued an “underweight” rating and issued a $134.00 price objective (down previously from $144.00) on shares of Clorox in a research report on Monday, September 30th. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price target for the company in a report on Monday, July 29th. Citigroup lowered their price target on shares of Clorox from $167.00 to $163.00 and set a “neutral” rating for the company in a report on Thursday, October 3rd. Finally, Wells Fargo & Co reaffirmed a “hold” rating and set a $150.00 price target on shares of Clorox in a report on Wednesday, October 2nd. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $152.25.
Shares of Clorox stock traded down $0.50 during trading hours on Friday, reaching $150.25. The company’s stock had a trading volume of 573,134 shares, compared to its average volume of 1,164,554. The stock has a market cap of $18.83 billion, a P/E ratio of 23.77, a price-to-earnings-growth ratio of 5.06 and a beta of 0.40. The company’s 50 day simple moving average is $155.25 and its 200 day simple moving average is $155.35. Clorox Co has a one year low of $142.00 and a one year high of $167.70. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.55 and a current ratio of 0.91.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The firm had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. Clorox’s quarterly revenue was down 3.8% compared to the same quarter last year. During the same period last year, the firm posted $1.66 EPS. On average, sell-side analysts predict that Clorox Co will post 6.14 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 30th will be paid a dividend of $1.06 per share. The ex-dividend date is Tuesday, October 29th. This represents a $4.24 annualized dividend and a yield of 2.82%. Clorox’s payout ratio is 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Special Dividends
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.